NCT05867849View on ClinicalTrials.gov

Cannabidiol for Bipolar Depression (CBD-BD)

PHASE3RecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

October 15, 2023

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2030

Conditions
Bipolar Disorder
Interventions
DRUG

Cannabidiol

Cannabinoid

OTHER

Placebo

Inactive substance

Trial Locations (6)

V6T 1Z3

RECRUITING

UBC Mood Disorders Centre, Vancouver

L8N 3K7

RECRUITING

St. Joseph's Healthcare, Hamilton

K7L 4X3

RECRUITING

Providence Care Hospital, Kingston

M4N 3M5

NOT_YET_RECRUITING

Sunnybrook Health Sciences Centre, Toronto

M6J1H4

NOT_YET_RECRUITING

Centre for Addiction and Mental Health (CAMH), Toronto

H4H 1R3

NOT_YET_RECRUITING

Douglas Mental Health University Institute, Montreal

All Listed Sponsors
lead

University of British Columbia

OTHER